Hasegawa H - Search Results

1

Clinical effect of low molecular weight heparin (fragmin) on DIC: a multicenter cooperative study in Japan.

Oguma Y, Sakuragawa N, Maki M, Nakagawa M, Hasegawa H. Oguma Y, et al. Among authors: hasegawa h. Thromb Res. 1990 Jul 1;59(1):37-49. doi: 10.1016/0049-3848(90)90269-i. Thromb Res. 1990. PMID: 2169078 Clinical Trial.

2

Treatment of disseminated intravascular coagulation with low molecular weight heparin. Research Group of FR-860 on DIC in Japan.

Oguma Y, Sakuragawa N, Maki M, Hasegawa H, Nakagawa M. Oguma Y, et al. Among authors: hasegawa h. Semin Thromb Hemost. 1990 Oct;16 Suppl:34-40. Semin Thromb Hemost. 1990. PMID: 1962902 Clinical Trial.

3

Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC)--a multicenter co-operative double-blind trial in comparison with heparin.

Sakuragawa N, Hasegawa H, Maki M, Nakagawa M, Nakashima M. Sakuragawa N, et al. Among authors: hasegawa h. Thromb Res. 1993 Dec 15;72(6):475-500. doi: 10.1016/0049-3848(93)90109-2. Thromb Res. 1993. PMID: 8128454 Clinical Trial.

4

An evaluation of fibrinolytic therapy of pulmonary thromboembolism using non-invasive examinations and the relationship of urokinase dosage to clinical outcome and coagulation-fibrinolytic changes.

Oguma Y, Hasegawa H, Kawakami Y. Oguma Y, et al. Among authors: hasegawa h. Jpn Circ J. 1988 Feb;52(2):131-8. doi: 10.1253/jcj.52.131. Jpn Circ J. 1988. PMID: 3361699

5

[Heparin therapy for myocardial infarction (author's transl)].

Hasegawa H, Oguma Y. Hasegawa H, et al. Rinsho Ketsueki. 1981 Jul;22(7):1044-52. Rinsho Ketsueki. 1981. PMID: 7328764 Japanese. No abstract available.

6

[Assay of plasma heparin and heparin-antithrombin III complex--studies in normal volunteers and thromboembolic patients].

Oguma Y, Hasegawa H, Nagata H, Kawakami Y. Oguma Y, et al. Among authors: hasegawa h. Rinsho Ketsueki. 1986 May;27(5):723-9. Rinsho Ketsueki. 1986. PMID: 3747167 Japanese. No abstract available.

7

The role of diagnostic criteria, isotopic perfusion defect and alveolar-arterial oxygen difference in the differential diagnosis of pulmonary thromboembolism and the evaluation of fibrinolytic therapy.

Oguma Y, Hasegawa H, Kawakami Y. Oguma Y, et al. Among authors: hasegawa h. Hokkaido Igaku Zasshi. 1987 May;62(3):501-10. Hokkaido Igaku Zasshi. 1987. PMID: 3610042

8

Assay of heparin in plasma using a chromogenic substrate and its clinical applications.

Hasegawa H, Oguma Y, Takei H, Seya T, Yamauchi M, Murakoshi T, Nagata H, Murao M. Hasegawa H, et al. Jpn Heart J. 1980 May;21(3):367-80. doi: 10.1536/ihj.21.367. Jpn Heart J. 1980. PMID: 7401317

9

[Evaluation of the assay for alpha 2PI and alpha 2PI-plasmin complex using the one-step sandwich method (EIA)].

Aoki N, Takenaga T, Hasegawa H, Oguma Y, Kobayashi N, Sakata Y, Fujimaki M, Ikematsu S, Kuroso K, Matsuda T, et al. Aoki N, et al. Among authors: hasegawa h. Rinsho Byori. 1987 Nov;35(11):1275-81. Rinsho Byori. 1987. PMID: 2965268 Japanese. No abstract available.

10

[FPA (fibrinopeptide A) and B beta 15-42)].

Hasegawa H, Oguma Y. Hasegawa H, et al. Rinsho Byori. 1987 Apr;Spec No 70:233-9. Rinsho Byori. 1987. PMID: 3302393 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,910 results

Search Page

Filters